Gardner Lewis Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Gardner Lewis Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-469,194	Closed	-$35.2M	–	127
2015 Q3	$35.2M	Buy	+469,194	New	+$35M	4.98%	2

Gardner Lewis Asset Management's KYTH Position: Q4 2015 in Review

Gardner Lewis Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 469,194 shares — an estimated $35.2M sold.

Gardner Lewis Asset Management first reported a position in KYTH in Q3 2015 and held it in 1 quarter. The position peaked at $35.2M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Gardner Lewis Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Gardner Lewis Asset Management sold 469,194 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $35.2M.
Gardner Lewis Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2015 and held it in 1 quarter.
Gardner Lewis Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $35.2M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.